The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review

被引:44
作者
Aucoin, Monique [1 ]
Cooley, Kieran [1 ,2 ,3 ]
Saunders, Paul Richard [1 ]
Cardozo, Valentina [1 ]
Remy, Daniella [1 ]
Cramer, Holger [2 ,4 ]
Abad, Carlos Neyre [5 ]
Hannan, Nicole [6 ]
机构
[1] Canadian Coll Naturopath Med, Toronto, ON, Canada
[2] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Sydney, NSW, Australia
[3] Pacific Coll Hlth Sci, San Diego, CA USA
[4] Univ Duisburg Essen, Fac Med, Dept Internal & Integrat Med, Kliniken Essen Mitte, Essen, Germany
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Griffith Univ, Sch Pharm & Pharmacol, Gold Coast, Qld, Australia
关键词
Quercetin; Respiratory tract infection; COVID; COVID-19; Rapid review; ILLNESS;
D O I
10.1016/j.aimed.2020.07.007
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Brief overview: There is currently insufficient evidence to recommend quercetin supplementation as a therapy for the treatment or prevention of COVID-19. Three human clinical trials with low risk of bias suggest that oral quercetin may have a beneficial effect on the incidence and duration of respiratory tract infections in certain populations; however, further research is needed. Verdict: Current evidence on the efficacy of quercetin supplementation in the treatment and prevention of COVID-19 is insufficient for its clinical recommendation at this time. Quercetin exhibits both immunomodulatory and antimicrobial effects in preclinical studies; however, only three human clinical trials, each with a low risk of bias rating, were identified in this rapid review. One study reported a decrease in incidence of upper respiratory tract infections following a competitive athletic event. A larger community clinical trial reported a benefit in older, athletic adults only. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 4 条
[1]   Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial [J].
Heinz, Serena A. ;
Henson, Dru A. ;
Austin, Melanie D. ;
Jin, Fuxia ;
Nieman, David C. .
PHARMACOLOGICAL RESEARCH, 2010, 62 (03) :237-242
[2]   Post-160-km Race Illness Rates and Decreases in Granulocyte Respiratory Burst and Salivary IgA Output are Not Countered by Quercetin Ingestion [J].
Henson, D. ;
Nieman, D. ;
Davis, J. M. ;
Dumke, C. ;
Gross, S. ;
Murphy, A. ;
Carmichael, M. ;
Jenkins, D. P. ;
Quindry, J. ;
McAnulty, S. ;
McAnulty, L. ;
Utter, A. ;
Mayer, E. .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2008, 29 (10) :856-863
[3]   Quercetin reduces illness but not immune perturbations after intensive exercise [J].
Nieman, David C. ;
Henson, Dru A. ;
Gross, Sarah J. ;
Jenkins, David P. ;
Davis, J. Mark ;
Murphy, E. Angela ;
Carmichael, Martin D. ;
Dumke, Charles L. ;
Utter, Alan C. ;
McAnulty, Steven R. ;
McAnulty, Lisa S. ;
Mayer, Eugene P. .
MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2007, 39 (09) :1561-1569
[4]   Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry [J].
Wu, Wenjiao ;
Li, Richan ;
Li, Xianglian ;
He, Jian ;
Jiang, Shibo ;
Liu, Shuwen ;
Yang, Jie .
VIRUSES-BASEL, 2016, 8 (01)